Resistell, a leader in phenotypic nanomotion technology for measuring living cells, based in Muttenz, Switzerland, has taken another major step to achieving its vision by closing a first tranche of its series B financing round
Search Results for: vischer
Jonas D. Gassmann has been promoted to counsel and new head of white-collar crime at VISCHER effective from 1 January 2023. Gassmann is an attorney at law who specialises in intellectual property law and white-collar crime. Media
TX Group and its subsidiary Goldbach have signed a binding agreement for the acquisition of Clear Channel Holding Switzerland, a driver for innovation in the Out-of-Home (OOH) advertising business, from Clear Channel International Limited. Goldbach
As we have informed last 15th December 2022 here, L-GAM, a mid-market private equity investment firm, has invested in Cotta Group, headquartered in Bendern (Liechtenstein), alongside Peter Gschwend. AFINUM has sold its stake in Cotta Collection
As we have informed last 15 November 2022 here, Hangzhou GreatStar Industrial, whose A Shares are listed on the Shenzhen Stock Exchange, became the eighth Chinese company that has listed global depositary receipts (GDRs) on the SIX
Anokion, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, recently closed an USD 35 million equity investment from Pfizer through the Pfizer Breakthrough Growth Initiative. Founded in Switzerland and based
Norgine Ventures has provided financing of approx. EUR 10 million to Lunaphore Technologies, a privately owned Swiss company spun out from EPFL. The financing was realised in form of private bonds with warrants which can be
Bratschi has appointed three new partners and of counsel on its Basel’s office. Marco Giavarini, Marius Meier and Orlando Meyer have been appointed partners and Christop Grether, of counsel. Marco Giavarini advises clients primarily
Cembra Money Bank, a renowed Swiss provider of financing solutions and services, has announced that it has agreed to acquire a 100% stake in Byjuno and its sister company, Intrum Finance Services, from Intrum for a
Versantis, a private Swiss-based clinical stage biotechnology company focused on addressing the growing unmet medical needs in liver diseases, is to be sold to Genfit. With this acquisition, Genfit intends to expand its product portfolio